SCHEMBL23911731

SCHEMBL23911731

O=P(c1ccccc1)(N1c2ccccc2C(c2ccccc2)(c2ccccc2)c2ccccc21)N1c2ccccc2C(c2ccccc2)(c2ccccc2)c2ccccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.36
▸ CNR1 P21554 1/20 0.34
▸ GPR55 Q9Y2T6 1/20 0.34
▸ CA2 P00918 1/20 0.32
▸ CA4 P22748 1/20 0.32
▸ CA5A P35218 1/20 0.32
▸ P2RX1 P51575 1/20 0.32
▸ P2RX3 P56373 1/20 0.32
▸ P2RX4 Q99571 1/20 0.32
▸ P2RX7 Q99572 1/20 0.32
▸ USP2 O75604 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ PAX8 Q06710 1/20 0.32
▸ MCL1 Q07820 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ MEN1 O00255 3/20 0.31
▸ KMT2A Q03164 3/20 0.31
▸ ADRB2 P07550 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23911725 0.81 MAPT (0.41) LMNACA2CA4CA5AUSP2
SCHEMBL23911740 0.79 LMNA (0.33) LMNACNR1GPR55P2RX1P2RX3
SCHEMBL23911698 0.75 KCNA5 (0.40) LMNAALDH1A1GAAMEN1KMT2A
SCHEMBL19367116 0.74 LMNA (0.33) LMNACNR1GPR55ALDH1A1MEN1
SCHEMBL20160481 0.70 LMNA (0.38) LMNACNR1GPR55P2RX1P2RX3
SCHEMBL21387931 0.70 LMNA (0.41) LMNACNR1GPR55P2RX1P2RX3
SCHEMBL280034 0.70 LMNA (0.47) LMNACNR1GPR55P2RX1P2RX3
SCHEMBL18387330 0.70 P2RX1 (0.41) LMNACNR1GPR55P2RX1P2RX3
SCHEMBL30585081 0.70 LMNA (0.47) LMNACNR1GPR55P2RX1P2RX3
SCHEMBL17189553 0.69 BCHE (0.46) LMNAL3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220020937-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2022-01-20 — — US disclosed
US-11145823-B2 Heterocyclic compound and organic light emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2021-10-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11145823-B2 Heterocyclic compound and organic light emitting device including the same TRPC1, ODC1, DDT LMNA 889/4885CNR1 2546/4885GPR55 2574/4885
US-20220020937-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME TRPC1, ODC1, DDT LMNA 810/4885CNR1 2438/4885GPR55 2765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback